Chronic Obstructive Pulmonary Disease Market - Top Companies are Ario Pharma, Asmacure, BioMarck Pharmaceuticals, Aquinox Pharmaceuticals, Astellas Pharma, AstraZenca Plc, Novartis AG
Chronic obstructive pulmonary disease (COPD), is an obstructive disease which is characterised by the long-term difficulty in breathing. Chronic obstructive pulmonary disease is the fifth-leading cause of death globally and COPD is one of the leading cause of morbidity and mortality worldwide. According to World Health Care (WHO), COPD mainly occurs mostly in the under developed countries. Also, in 2016 the global burden of diseases study reported 251 million cases of COPD globally. Chronic obstructive pulmonary disease is characterised by the symptoms such as; shortness of breath, frequent coughing, wheezing, tightness in the chest and cough with/without Sputum production.
Download PDF Sample:https://bit.ly/2P6ZeDN
Chronic obstructive pulmonary disease, is majorly influenced by the factors such as increasing air pollution, poorly vented heating and cooking smoke, long exposures to the irritants that cause inflammatory response to the lungs. It can be prevented by controlling the risk factors like reducing smoking, and improving the indoor and outdoor air quality. However, chronic obstructive pulmonary disease is not curable, but can be controlled with various types of drugs. Hence, considering this factor the major players are continuously focusing on the new drug development and approvals. For instance, recently Umeclidinium Bromide by GlaxoSmithKline is considered to be a promising molecule for treating COPD.
Rising prevalence of chronic obstructive pulmonary disorder in the developing countries and changing lifestyle will support the growth of chronic obstructive pulmonary disease market.
The global chronic obstructive pulmonary disorder market is primarily driven by increasing number of patients suffering from COPD. Figures for 2015 state that approximately 3.1 million deaths were reported due to COPD which amount to 5% of the deaths globally. In addition, factors that augment the growth of chronic obstructive pulmonary disease market size are rising government initiatives for developing new drugs and promoting easy practices for drug approval in various regions.
On the other hand, increasing technological advancements for developing effective products including nebulizers will also spur this market. Likewise, increasing tobacco consumption is expected to accelerate the chronic obstructive pulmonary disease market growth during the forecast period.
However, high cost of available treatments, recent patents expiries, and continuous development of generic drugs owning to its cost effectiveness would affect the growth of chronic obstructive pulmonary disease market.
Global chronic obstructive pulmonary disease Market Taxonomy
The global chronic obstructive pulmonary disease market size is segmented on the basis of cancer type, diagnostic techniques, treatment type, end users, and geography.
Geographically, the chronic obstructive pulmonary disease market share is categorized into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
Increased expenditure on R&D for developing new and effective drugs to lead the global chronic obstructive pulmonary disease market in North America.
Geographically, the global chronic obstructive pulmonary disease market share is segmented into North America, Europe, Asia Pacific, Latin America & Middle East and Africa. North America is expected to dominate the chronic obstructive pulmonary disease market over the forecast period. North America holds major share owing to the ongoing clinical trials by the increasing R&D investments by the major players and the government. While, increasing awareness for the use of drugs would also spur the chronic obstructive pulmonary disease market of North America. Also, Europe region has comparatively large number of population suffering from COPD.
However, Asia Pacific is relied to grow faster during the forecast period. Increasing number of patients with COPD, rising intake of tobacco by the youths, and increased awareness for the use of generic drugs to boost chronic obstructive pulmonary disease market during upcoming years.
Key players in the global chronic obstructive pulmonary disease market are:
Ache Laboratorios Famaceuticos
For More Information and TOC: https://bit.ly/2yK5eZ1
About Polaris Market Research:
Polaris Market Research is a global market research and consulting company. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments and latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises.
Corporate Sales, USA
Polaris Market Research
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Chronic Obstructive Pulmonary Disease Market - Top Companies are Ario Pharma, Asmacure, BioMarck Pharmaceuticals, Aquinox Pharmaceuticals, Astellas Pharma, AstraZenca Plc, Novartis AG here
News-ID: 1350173 • Views: 554
More Releases from Polaris Market Research & Consulting
What's driving the Blockchain Technology Market Trends? Microsoft Corporation, I …
The worldwide market size for blockchain technology is estimated to grow at a CAGR of 41.6% between 2018 and 2026 and is anticipated to reach USD 16.82 billion by 2026. According to a new study published by Polaris Market Research. Also termed as Distributed Ledger Technology (DLT), blockchain enables secure transaction over a distributed network. Since the transactions are taken place usually over the network, it is difficult to reverse
What's driving the Precision Farming Market Trends? Ag Leader Technology, AgJunc …
The global precision farming/agriculture market was valued at 3,833 million in 2017 and is anticipated to reach over USD 13,016 million by 2026 with grow at a CAGR of more than 14.7% during the forecast period According to a new study published by Polaris Market Research. In 2017, the yield monitoring application dominated the global market, in terms of revenue. North America is expected to be the leading contributor to
What are the different trends in Electric Vehicles (EV) Market to boost its grow …
Polaris Market Research has new report published the addition of the “The global Electric Vehicles Market Worth $912 Billion By 2026 | CAGR: 38.4%”, the report classifies the global Electric Vehicles market in a precise manner to offer unearth valuable, accurate and reliable data insights that help organizations to meet their business objectives and enable growth Get PDF Sample of “Electric Vehicles Market”: https://www.polarismarketresearch.com/industry-analysis/electric-vehicles-ev-market/request-for-sample The global electric vehicles market is anticipated to
What are the different trends in Third Party Logistics Market to boost its growt …
Polaris Market Research has new report published the addition of the “The global third-party logistics market is anticipated to reach USD 1,337.91 billion by 2026”, the report classifies the global third-party logistics market in a precise manner to offer unearth valuable, accurate and reliable data insights that help organizations to meet their business objectives and enable growth according to a new report The report “Third Party Logistics (3PL) Market Share, Size,
More Releases for COPD
COPD Therapeutics Global Market Research Report 2019
COPD Therapeutics Report by Material, Application, and Geography � Global Forecast to 2022 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China). Access more details about this report at: https://www.research2reports.com/report-medical-devices/copd-therapeutics-market/80858 The report firstly introduced the COPD Therapeutics basics: definitions, classifications, applications and market
Asthma and COPD Drugs Market worth $50,359 Million by 2022
"The key players of the Global COPD and asthma drugs market are employing novel concepts and ideas to improve, manage and control asthma & COPD, and also enhance their profitability so as to gain a competitive edge over the other market players. Seretide/Advair, Symbicort, and Singular were leading brands and accounted for around one-fourth share in world COPD and asthma drugs market." Global Asthma and COPD Drugs Market was valued at
Alarming Prevalence of COPD to Propel Oxygen Therapy Devices Market
"Oxygen therapy equipment market driven by increasing urbanization and rising levels of air pollution." An intelligence report on the global oxygen therapy equipment market has been added to the burgeoning portfolio of MarketResearchReports.biz. Titled, “Global Oxygen Therapy Equipment Market - Analysis By Product, Portability, Application, Region, Country: Opportunities and Forecast (2017- 2022) - By Product (Oxygen Concentrators, Liquid Oxygen Devices and Oxygen Cylinders), By Portability (Stationary, Portable Devices), By Application (COPD,
Asthma and COPD Drugs Market | Key Opportunities And Forecast 2024
The top five companies in the U.S. and China Asthma And Copd Drugs Market accounted for just under 64.0% in 2015, hinting at not just the consolidated nature of this industry but also at the immense competition among players. GlaxoSmithKline plc, Astrazeneca plc, Boehringer Ingelheim, Merck & Co. Inc., and Novartis AG currently enjoy the leading spots in the asthma and COPD drugs market. According to Transparency Market Research, the opportunity
Global COPD and Asthma Devices Market Size
According to a new report, Global COPD and Asthma Devices Market, published by KBV Research, The Global COPD and Asthma Devices Market attained a market size of $ 27,465.1 Million in 2015 and is expected to reach $ 39,051.4 Million by 2022 growing at a CAGR of 5.2 % CAGR during 2016 – 2022. The Asia Pacific market dominated the Global COPD and Asthma Devices Market in 2015 and would
COPD Drug Market Opportunity & Clinical Pipeline Analysis
Close to 1 Billion people worldwide suffer from respiratory or pulmonary diseases. In the respiratory therapeutic domain, Asthma and COPD are the major categories, accounting for close to 75% of the total patient for respiratory or pulmonary diseases. Chronic obstructive pulmonary disease (COPD) is a disease which progresses in the lungs and requires treatment all through the life. It is an inflammatory disorder which is characterized by obstruction in the